Dear partners and friends,
We from Sciomics are hoping that you are all safe and well and would like to give you an update on our current activities in these challenging times.
To limit the spread of the COVID-19 virus and to ensure the safety of our employees as well as the continuation of all projects, Sciomics has early implemented preventive actions which have recently been further increased:
- only people critical to the laboratory activity are present on site
- implementation of non-overlapping teams for all on-site activities
- efficient home office capabilities for all personnel
Through these actions, all our protein and post-translational analysis capabilities remain fully operational and we are able to continue all active projects as well as to begin new studies in the foreseeable future.
Please feel free to contact us at any time if you have any questions or like to discuss how we may support you best during the current situation as well as in future projects.
As health is the highest good, we wish you all the best for you as well as your families and loved ones.
Our protein biomarker discovery and development pipeline
Our comprehensive protein profiling services
- Biomarker discovery and verification studies
- Drug target discovery and verification
- Mode-of-Action Analysis
- Pre-clinical assessment of novel compounds
- Characterization and selection of cell culture or animal models
- Pathway profiling and pathway activity analysis
- Cytokine profiling
- Immune response profiling